Omada Health, Inc.
For the period ended Sep 30, 2026. Filed Nov 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
9. Segment Reporting
- Segment Reporting
The Company hasone operating and reportable segment, which includes all virtual care program product offerings. The CODM manages the allocation of resources and assesses performance at the operating segment level.
The CODM reviews information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. The CODM assesses performance and decides how to allocate resources based on components reported on the condensed consolidated statement of operations including consolidated net income (loss). The CODM uses net income (loss) to evaluate the return on assets and to determine investment opportunities related to development of new virtual care service offerings, new technologies, and platform enhancements. The CODM also uses net income (loss) to monitor budget versus actual results.
The Company’s segment net income (loss) and significant expenses for the three and nine months ended September 30, 2026 and 2025, consisted of the following (in thousands):
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Revenue | $91,306 | $68,030 | $257,189 | $184,364 |
| Cost of revenue (1) | 22,024 | 22,959 | 75,427 | 67,087 |
| Employee compensation (2) | 42,283 | 32,834 | 121,025 | 93,748 |
| Other segment items (3) | 20,448 | 15,415 | 51,862 | 41,466 |
| Consolidated net income (loss) | $6,551 | $(3,178) | $8,875 | $(17,937) |
(1)Depreciation and amortization included in cost of revenue was $1.6 million and $0.8 million for the three months ended September 30, 2026 and 2025, respectively, and $4.5 million and $2.4 million for the nine months ended September 30, 2026 and 2025, respectively.
(2)Employee compensation is part of research and development, sales and marketing and general and administrative expenses and includes salaries, share-based compensation expense, sales commissions, employee bonuses, benefits, and other employee related expenses.
(3)Other segment items include third-party consulting services and professional services, software and infrastructure, hosting, marketing and advertising, and other income and other expenses.
All of the Company’s long-lived assets were located in the U.S., and all revenue was earned in the U.S. as of December 31, 2025 and for the three and nine months ended September 30, 2026 and 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.